(b) Stimulation of lymphangiogenesis by vascular endothelial growth factor C (VEGF-C) and its receptor (VEGFR3) attenuates RA joint damage, and inhibiting lymphangiogenesis with a VEGF inhibitor accelerates RA joint damage. The gene discussed is VEGFC; the disease is rheumatoid arthritis.